Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies

Vandercam, Bernard; Ezzeddine, H.; Agaliotis, D.; Gala, Jean-Luc; Gigi, J.; Wauters, Georges; Michaux, J.L.

doi:10.1080/17843286.1989.11717996

Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies

Vandercam, Bernard

;

Ezzeddine, H.

;

Agaliotis, D.

;

Gala, Jean-Luc

;

Michaux, J.L.

;et.al.

(1989) Acta Clinica Belgica (Multilingual Edition) — Vol. 44, n° 2, p. 99-109 (1989)

Files

52336.pdf

Restricted Access
Adobe PDF
1.44 MB

Request a copy

Details

Authors

Vandercam, BernardUCLouvain
Author
Ezzeddine, H.
Author
Agaliotis, D.
Author
Gala, Jean-LucUCLouvain
Author
Wauters, GeorgesUCLouvain
Author
Michaux, J.L.
Author

Affiliations

Citations

APA
Chicago
FWB

Vandercam, B., Ezzeddine, H., Agaliotis, D., Gala, J.-L., Gigi, J., Wauters, G., & Michaux, J. L. (1989). Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies. Acta Clinica Belgica (Multilingual Edition), 44(2), 99-109. https://doi.org/10.1080/17843286.1989.11717996 (Original work published 1989)